IBA Lifesciences

IBA Lifesciences, founded in 1996, is a global innovative producer of life science products. Deeply engaged in cutting-edge technological innovation, and based on the outstanding patented Strep-tag® system, it provides a series of products covering the expression, purification, and immobilization of recombinant proteins, as well as the separation of specific cells/exosomes from whole blood/related body fluids. The company operates in more than 40 countries and regions worldwide, offering high-quality and competitive products and services to research institutions and corporate clients. Core technology: Strep-tag® technology. The principle of Strep-tag® technology utilizes one of the strongest non-covalent interactions in nature: the interaction between biotin and streptavidin.